Clinical Medicine and Pharmacology Clinical Medicine and Pharmacology Клиническая медицина и фармакология 2409-3750 19991 10.12737/article_5a72e5f69abd12.30490466 Актуальные вопросы фармакотерапии topical issues of pharmacotherapy Актуальные вопросы фармакотерапии EVOLUTION OF METHODS OF INTRODUCTION OF PHARMACOLOGICAL PREPARATIONS ЭВОЛЮЦИЯ СПОСОБОВ ВВЕДЕНИЯ ФАРМАКОЛОГИЧЕСКИХ ПРЕПАРАТОВ Заволко М. С. Zavolko M. S. Никифоров А. В. Nikiforov A. V. Токарев А. Р. Tokarev A. R. Киреев Семен Семенович Kireev Semen Semenovich Наумов А. В. Naumov A. V. Елисеенков О. Н. Eliseenkov O. N. Шелухина Н. В. Sheluhina N. V. Никифорова Е В. Nikiforova E V. Тульский государственный университет Тула Россия Тульский государственный университет Тула Russian Federation Тульский государственный университет Тула Россия Тульский государственный университет Тула Russian Federation Тульский государственный университет Тула Россия Тульский государственный университет Тула Russian Federation Тульский государственный университет Тула Россия Тульский государственный университет Тула Russian Federation ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Россия ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Russian Federation ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Россия ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Russian Federation ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Россия ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Russian Federation ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Россия ГУЗ Тульская городская клиническая больница скорой медицинской помощи им. Д.Я. Ваныкина Тула Russian Federation 3 4 54 58 https://zh-szf.ru/en/nauka/article/19991/view

В статье проведен обзор литературы по оптимизации путей введения лекарственных средств. Про- веден анализ основных действующих способов доставки фармакологических препаратов с описанием их преимуществ и недостатков. Более широко освещен ингаляционный путь введения, как наиболее современный и перспективный.

В статье проведен обзор литературы по оптимизации путей введения лекарственных средств. Про- веден анализ основных действующих способов доставки фармакологических препаратов с описанием их преимуществ и недостатков. Более широко освещен ингаляционный путь введения, как наиболее современный и перспективный.

 способы доставки лекарственных средств ингаляционный путь введения современный способ доставки лекарств анестезиология премедикация

Chong CR, Sullivan D J. New uses for old drugs. Nature 2007; 448: 645-646 Chong CR, Sullivan D J. New uses for old drugs. Nature 2007; 448: 645-646 Benni JM, Patil PA. J Basic Clin Physiol Pharmacol. Non-diabetic clinical applications of insulin.2016 Sep 1;27(5):445-56. Benni JM, Patil PA. J Basic Clin Physiol Pharmacol. Non-diabetic clinical applications of insulin.2016 Sep 1;27(5):445-56. She P, Wang Y, Luo Z, Chen L, Tan R, Wang Y, Wu Y. Meloxicam inhibits biofilm formation and enhances antimicrobial agents efficacy by Pseudomonas aeruginosa. Microbiologyopen. 2017 Nov 27. She P, Wang Y, Luo Z, Chen L, Tan R, Wang Y, Wu Y. Meloxicam inhibits biofilm formation and enhances antimicrobial agents efficacy by Pseudomonas aeruginosa. Microbiologyopen. 2017 Nov 27. World Health Organization. Development of Paediatric Medicines: Points to Consider in Formulation. Geneva, Switzerland: World Health Organization; 2012. WHO Technical Report Series, No. 970, Annex 5 World Health Organization. Development of Paediatric Medicines: Points to Consider in Formulation. Geneva, Switzerland: World Health Organization; 2012. WHO Technical Report Series, No. 970, Annex 5 European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. EMA/CHMP/QWP/805880/2012 Rev. 2 European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. EMA/CHMP/QWP/805880/2012 Rev. 2 Бертрам Г.Кацунг Базисная и клиническая фармакология в 2х томах, 2 издание М:Бином 2007: том 1, 75 Bertram G.Kacung Bazisnaya i klinicheskaya farmakologiya v 2h tomah, 2 izdanie M:Binom 2007: tom 1, 75 Avinash Y Kaushik, Ajay K Tiwari, and Ajay Gaur Role of excipients and polymeric advancements in preparation of floating drug delivery systems Int J Pharm Investig. 2015 Jan-Mar; 5(1): 1-12. Avinash Y Kaushik, Ajay K Tiwari, and Ajay Gaur Role of excipients and polymeric advancements in preparation of floating drug delivery systems Int J Pharm Investig. 2015 Jan-Mar; 5(1): 1-12. Back DJ1, Rogers SM Review: first-pass metabolism by the gastrointestinal mucosa. Aliment Pharmacol Ther. 1987 Oct;1(5):339-57 Back DJ1, Rogers SM Review: first-pass metabolism by the gastrointestinal mucosa. Aliment Pharmacol Ther. 1987 Oct;1(5):339-57 Breitkreutz J, Wessel T, Boos J. 13. Dosage forms for oral drug administration. In: Choonara I, Nunn T, Kearns G, eds. Introduction to Paediatric and Perinatal Drug Therapy. Nottingham, UK: Nottingham University Press;2003:189-205 Breitkreutz J, Wessel T, Boos J. 13. Dosage forms for oral drug administration. In: Choonara I, Nunn T, Kearns G, eds. Introduction to Paediatric and Perinatal Drug Therapy. Nottingham, UK: Nottingham University Press;2003:189-205 Marconati M, Raut S, Burbidge A, Engmann J, Ramaioli M An in vitro experiment to simulate how easy tablets are to swallow. Int J Pharm. 2017 Oct 18;535(1-2):27-37 Marconati M, Raut S, Burbidge A, Engmann J, Ramaioli M An in vitro experiment to simulate how easy tablets are to swallow. Int J Pharm. 2017 Oct 18;535(1-2):27-37 Rudralingam M, Randall C, Mighell AJ The use of topical steroid preparations in oral medicine in the UK Br Dent J. 2017 Dec;223(9):633-638 Rudralingam M, Randall C, Mighell AJ The use of topical steroid preparations in oral medicine in the UK Br Dent J. 2017 Dec;223(9):633-638 van Hoogdalem E, de Boer AG, Breimer DD Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet. 1991 Jul;21(1):11-26. van Hoogdalem E, de Boer AG, Breimer DD Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs. Clin Pharmacokinet. 1991 Jul;21(1):11-26. Netter FH, Hansen JT, Atlas Human of Anatomy 3rd edition 2003: 300-303 Netter FH, Hansen JT, Atlas Human of Anatomy 3rd edition 2003: 300-303 de Boer AG, Moolenaar F, de Leede LG, Breimer DD Rectal drug administration: clinical pharmacokinetic considerations Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311 de Boer AG, Moolenaar F, de Leede LG, Breimer DD Rectal drug administration: clinical pharmacokinetic considerations Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311 Quintana DS, Alvares GA, Hickie IB, Guastella AJ. Neurosci Biobehav Rev Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model. 2015; 49: 182-192. Quintana DS, Alvares GA, Hickie IB, Guastella AJ. Neurosci Biobehav Rev Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model. 2015; 49: 182-192. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH II. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration Neuroscience 2004; 127: 481-496. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH II. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration Neuroscience 2004; 127: 481-496. Yamamoto A, Iseki T, Ochi-Sugiyama M, Okada N, Fujita T, Muranishi S. Absorption of water-soluble compounds with different molecular weights and [Asu1.7]-eel calcitonin from various mucosal administration sites. J Control Release 2001; 76: 363-374. Yamamoto A, Iseki T, Ochi-Sugiyama M, Okada N, Fujita T, Muranishi S. Absorption of water-soluble compounds with different molecular weights and [Asu1.7]-eel calcitonin from various mucosal administration sites. J Control Release 2001; 76: 363-374. Guastella AJ, Hickie IB, McGuinness MM, Otis M, Woods EA, Disinger HM et al Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research . Psychoneuroendocrinology 2013; 38: 612-625. Guastella AJ, Hickie IB, McGuinness MM, Otis M, Woods EA, Disinger HM et al Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research . Psychoneuroendocrinology 2013; 38: 612-625. Miller JL, Ashford JW, Archer SM, Rudy AC, Wermeling DP. Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study. Pharmacotherapy 2008; 28: 875-882. Miller JL, Ashford JW, Archer SM, Rudy AC, Wermeling DP. Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study. Pharmacotherapy 2008; 28: 875-882. Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003 May-Aug;6(2):252-73. Misra A, Ganesh S, Shahiwala A, Shah SP. Drug delivery to the central nervous system: a review. J Pharm Pharm Sci. 2003 May-Aug;6(2):252-73. Rosenbaum SE, Basic pharmacokinetics and pharmacodynamics, 2nd Edition. Hoboken, New Jersey : John Wiley & Sons, Inc., 2017. Rosenbaum SE, Basic pharmacokinetics and pharmacodynamics, 2nd Edition. Hoboken, New Jersey : John Wiley & Sons, Inc., 2017. Gradon L., Sosnowski T.R. Formation of particles for dry powder inhalers. Advanced Powder Technology Volume 25, Issue 1, January 2014: 43-55. Gradon L., Sosnowski T.R. Formation of particles for dry powder inhalers. Advanced Powder Technology Volume 25, Issue 1, January 2014: 43-55. Tuncer DI, Nevin C. Controlled Delivery of Peptides and Proteins. Curr Pharm Des. 2007;13:99-117 Tuncer DI, Nevin C. Controlled Delivery of Peptides and Proteins. Curr Pharm Des. 2007;13:99-117 Ma JKH, Bhat M, Rojanasakul Y Drug metabolism and enzyme kinetics in the lung. In: Lenfant C, editor. Inhalation aerosols. Physical and biological basis for therapy. New York: Marcel Dekker Inc.; 1996. pp. 155-195. 94. Ma JKH, Bhat M, Rojanasakul Y Drug metabolism and enzyme kinetics in the lung. In: Lenfant C, editor. Inhalation aerosols. Physical and biological basis for therapy. New York: Marcel Dekker Inc.; 1996. pp. 155-195. 94. Сапин М.Р., Бочаров В.Я., Никитюк Д.Б., Сатюкова Г.С., Селин Ю.М., Спирин Б.А. Анатомия человека в 2х томах, 5 изд., М.Медицина 2001: том 2, 221-226 Sapin M.R., Bocharov V.Ya., Nikityuk D.B., Satyukova G.S., Selin Yu.M., Spirin B.A. Anatomiya cheloveka v 2h tomah, 5 izd., M.Medicina 2001: tom 2, 221-226 Patton JS Mechanisms of macromolecule absorption by the lungs. Advanced Drug Delivery Rev. 1996;19:3-36. Patton JS Mechanisms of macromolecule absorption by the lungs. Advanced Drug Delivery Rev. 1996;19:3-36. Smaldone GC, Perry RJ, Bennett WD, Messina MS, Zwang J, Ilowite J. Interpretation of ‘24 hour lung retention’ in studies of mucociliary clearance. J Aerosol Med. 1988;1:11-20. Smaldone GC, Perry RJ, Bennett WD, Messina MS, Zwang J, Ilowite J. Interpretation of ‘24 hour lung retention’ in studies of mucociliary clearance. J Aerosol Med. 1988;1:11-20. Evans CM, Koo JAS. Airway mucus: the good, the bad, the sticky. Pharmacol Therapeut. 2009;121:332-48. Evans CM, Koo JAS. Airway mucus: the good, the bad, the sticky. Pharmacol Therapeut. 2009;121:332-48. Londahl J, Massling A, Pagels J, Swietlicki E, Vaclavik E, Loft S. Size-resolved respiratory-tract deposition of fine and ultrafine hydrophobic and hygroscopic aerosol particles during rest and exercise. Inhal. Toxicol. 19(2), 109-16 (2007). Londahl J, Massling A, Pagels J, Swietlicki E, Vaclavik E, Loft S. Size-resolved respiratory-tract deposition of fine and ultrafine hydrophobic and hygroscopic aerosol particles during rest and exercise. Inhal. Toxicol. 19(2), 109-16 (2007). Dunne RB, Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med. 2017 Oct 31. Dunne RB, Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. Am J Emerg Med. 2017 Oct 31. Tashkin DP, Ferguson GT, Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease, Tashkin and Ferguson Respiratory Research 2013, http://respiratory-research.com/content/14/1/49 Tashkin DP, Ferguson GT, Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease, Tashkin and Ferguson Respiratory Research 2013, http://respiratory-research.com/content/14/1/49 Kerstjens Huib A.M., , Brand Paul L.P., Hughes MD., Robinson N. Jamie A Comparison of Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways Disease N Engl J Med 1992; 327:1413-1419 Kerstjens Huib A.M., , Brand Paul L.P., Hughes MD., Robinson N. Jamie A Comparison of Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways Disease N Engl J Med 1992; 327:1413-1419 Barker AF., Couch L., Fiel SB., Gotfried MH., Ilowite J., Meyer KC., O'donnell A. Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis American Journal of Respiratory and Critical Care Medicine Vol. 162, No. 2 | Aug 01, 2000 Barker AF., Couch L., Fiel SB., Gotfried MH., Ilowite J., Meyer KC., O'donnell A. Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis American Journal of Respiratory and Critical Care Medicine Vol. 162, No. 2 | Aug 01, 2000 Ryan G, Singh M, Dwan K Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev. 2011;3: CD001021. Ryan G, Singh M, Dwan K Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev. 2011;3: CD001021. Kapustina V., Ovcharenko S. The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis European Respiratory Journal 2013 42 Kapustina V., Ovcharenko S. The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis European Respiratory Journal 2013 42 Poole Ph., Black PN., Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev. 2010; 2 (CD001287.) Poole Ph., Black PN., Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev. 2010; 2 (CD001287.) Qiu Yuan-Hua, Chen En-Guo, Dai Yuan-Rong, Ren Zhen-Yi Efficacy and Safety of Domestic Inhaled N-acetyl-L-cysteine Solution in Mucolytic Therapy Chinese Pharmaceutical Journal 2012-21 Qiu Yuan-Hua, Chen En-Guo, Dai Yuan-Rong, Ren Zhen-Yi Efficacy and Safety of Domestic Inhaled N-acetyl-L-cysteine Solution in Mucolytic Therapy Chinese Pharmaceutical Journal 2012-21 Розенберг О. А., Легочный сурфактант и его применение при заболеваниях легких, Общая реаниматология, 2007, том 3; №1 Rozenberg O. A., Legochnyy surfaktant i ego primenenie pri zabolevaniyah legkih, Obschaya reanimatologiya, 2007, tom 3; №1 J.M.Borroa, A.Soléb, M.de la Torrea, A.Pastorb, R.Fernandeza, A.Saurab, M.Delgadoa, E.Monteb, D.Gonzaleza Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation Transplantation Proceedings Volume 40, Issue 9, November 2008, Pages 3090-3093 J.M.Borroa, A.Soléb, M.de la Torrea, A.Pastorb, R.Fernandeza, A.Saurab, M.Delgadoa, E.Monteb, D.Gonzaleza Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation Transplantation Proceedings Volume 40, Issue 9, November 2008, Pages 3090-3093 S. GargEmail authorJ. RosenstockB. L. SilvermanB. SunC. S. KonkoyA. de la PeñaD. B. Muchmore Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes Diabetologia May 2006, 49:891 S. GargEmail authorJ. RosenstockB. L. SilvermanB. SunC. S. KonkoyA. de la PeñaD. B. Muchmore Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes Diabetologia May 2006, 49:891 Abigail L. Chua, Stephen Silberstein Inhaled drug therapy development for the treatment of migraine Expert Opinion on Pharmacotherapy Volume 17, 2016 - Issue 13 Abigail L. Chua, Stephen Silberstein Inhaled drug therapy development for the treatment of migraine Expert Opinion on Pharmacotherapy Volume 17, 2016 - Issue 13 Roncero Carlos, Ros-Cucurull Elena, Grau-López Lara, Fadeuilhe Christian, Casas Miguel, Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients: A Case Series Clinical Neuropharmacology: July/August 2016 - Volume 39 - Issue 4 - p 206-209 Roncero Carlos, Ros-Cucurull Elena, Grau-López Lara, Fadeuilhe Christian, Casas Miguel, Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients: A Case Series Clinical Neuropharmacology: July/August 2016 - Volume 39 - Issue 4 - p 206-209 Timothy Aksamit, Tiemo-JoergBandel, MargaritaCriollo, Anthony De Soyza, J Stuart Elborn, ElisabethOperschall, Eva Polverino The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis Contemporary Clinical Trials Volume 58, July 2017, Pages 78-85 Timothy Aksamit, Tiemo-JoergBandel, MargaritaCriollo, Anthony De Soyza, J Stuart Elborn, ElisabethOperschall, Eva Polverino The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis Contemporary Clinical Trials Volume 58, July 2017, Pages 78-85 Kenneth N. Olivier, David E. Griffith, Gina Eagle, John P. McGinnis II, Liza Micioni, Keith Liu, Charles L. Daley, Kevin L. Winthrop, Stephen Ruoss, Doreen J. Addrizzo-Harris, Patrick A. Flume, Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease, American Journal of Respiratory and Critical Care Medicine, Vol. 195, No. 6 | Mar 15, 2017 Kenneth N. Olivier, David E. Griffith, Gina Eagle, John P. McGinnis II, Liza Micioni, Keith Liu, Charles L. Daley, Kevin L. Winthrop, Stephen Ruoss, Doreen J. Addrizzo-Harris, Patrick A. Flume, Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease, American Journal of Respiratory and Critical Care Medicine, Vol. 195, No. 6 | Mar 15, 2017 Onur Turan, Pakize Ayse Turan, Arzu Miric Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma, Geriatrics & Gerontology International ,Volume 17, Issue 6 June 2017 Pages 999-1005 Onur Turan, Pakize Ayse Turan, Arzu Miric Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma, Geriatrics & Gerontology International ,Volume 17, Issue 6 June 2017 Pages 999-1005 El Baou C, Di Santostefano RL, Alfonso-Cristancho R, et al. Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis. BMC Pulm Med. 2017;17(1):31 El Baou C, Di Santostefano RL, Alfonso-Cristancho R, et al. Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis. BMC Pulm Med. 2017;17(1):31 Tony Velkov, Nusaibah Abdul Rahim, Qi (Tony) Zhou, Hak-Kim Chan, Jian Lia Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead, Adv Drug Deliv Rev. 2015 May; 85: 65-82 Tony Velkov, Nusaibah Abdul Rahim, Qi (Tony) Zhou, Hak-Kim Chan, Jian Lia Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead, Adv Drug Deliv Rev. 2015 May; 85: 65-82 Jia-Wei Yang, Li-Chao Fan, Hai-Wen Lu, Xia-Yi Miao, Bei Mao, Jin-Fu Xu Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis, The Clinical Respiratory Journal, Volume 10, Issue 6 November 2016 Pages 731-739 Jia-Wei Yang, Li-Chao Fan, Hai-Wen Lu, Xia-Yi Miao, Bei Mao, Jin-Fu Xu Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis, The Clinical Respiratory Journal, Volume 10, Issue 6 November 2016 Pages 731-739 Jonkman K, Duma A, Velzen M, Dahan A. Br J Anaesth., Ketamine inhalation. 2017 Feb;118(2):268-269. Jonkman K, Duma A, Velzen M, Dahan A. Br J Anaesth., Ketamine inhalation. 2017 Feb;118(2):268-269.